Skip to main content
Fig. 7 | European Journal of Medical Research

Fig. 7

From: COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks

Fig. 7

A Distributions of COLGALT1 expression in five types of immune subtypes; TCIA database was utilized to predict the immune response of COLGALT1 to B PD1 immunotherapy; C CTLA4 immunotherapy; D PD1 and CTLA4 immunotherapies; TIDE results of E TIDE score; F T cell dysfunction score; G T cell exclusion score in different COLGALT1 subgroups; H, I Correlations between sensitivity of chemotherapy drugs with COLGALT1 expression in CellMiner database

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us